Calcifediol (25-Hydroxyvitamin D3) from Canada
Calcifediol is the 25-hydroxylated active metabolite of Vitamin D3, used primarily as a vitamin derivative in therapeutic supplements. It qualifies for HTS 2936.29.50.20 as a Vitamin D derivative that is a separate chemically defined organic compound essential for treating vitamin D deficiency. Supplied in high-purity crystalline form for pharmaceutical compounding.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include stability data showing no degradation during transport, as required for vitamin derivatives
• FDA prior notice required; file through ACE system 72 hours before arrival for dietary ingredients